Source: bioprocessonline.com In 2021, EXUMA Biotech plans to take its Rapid Point of Care (rPOC) platform to the clinic in hopes of proving out the viability of 6-hour vein-to-vein CAR T therapy administration in cancer patients. Gregory Frost, Ph.D., is perhaps best known for his 15-year tenure at Halozyme Therapeutics, the biopharma he co-founded in 1999 Read More
Tag: technologie
Upgrade & Secure Your Future with DevOps, SRE, DevSecOps, MLOps!
We spend hours on Instagram and YouTube and waste money on coffee and fast food, but won’t spend 30 minutes a day learning skills to boost our careers.
Master in DevOps, SRE, DevSecOps & MLOps!
Learn from Guru Rajesh Kumar and double your salary in just one year.